ClostraBio

Chicago, IL · Founded 2016 · Privately Held (backing)

Developer of biopharmaceuticals intended to offer therapeutics for food allergies. ClostraBio is based in Chicago, IL and was founded in 2016. It was valued at $16 million at its later-stage round in Sep 2022, the last priced event on record. It has raised $14.2 million across 1 recorded round; the latest was a $9.9 million early-stage round in Sep 2022.

PMV mark · valuation
$16.0M
Oct 2026
Priced at
its later-stage round
Sep 2022
Total raised
$14.2M
Last round
Early Stage VC
Sep 2022

Who backs ClostraBio?

10 investors
InvestorType
Polsky Center for Entrepreneurship and Innovation at the University of ChicagoOther
Mansueto OfficeFamily office
Angela Oakey—
Daniel Oakey—
New Venture Challenge—
NextGen Nutrition Investment Partners—
Portal Innovations—
Stone Mountain Ventures—
University of Chicago—
Wolf Point Capital—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

ClostraBio investors

10 investors are on record for ClostraBio, including Polsky Center for Entrepreneurship and Innovation at the University of Chicago, Mansueto Office, Angela Oakey and Daniel Oakey. The early-stage round in Sep 2022 drew 15 investors.

Free account
More of ClostraBio with a free account
  • ·Watch ClostraBio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 10 firms already write checks for companies like ClostraBio. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View